Dodge & Cox
REGN icon

Dodge & Cox’s Regeneron Pharmaceuticals REGN Stock Holding History

Dodge & Cox’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.04B Buy
4,871,137
+412,899
+9% +$281M 1.59% 18
2026
Q1 		$3.44B Sell
4,458,238
-138,120
-3% -$106M 1.89% 12
2025
Q4 		$3.55B Buy
4,596,358
+45,513
+1% +$30.9M 1.92% 10
2025
Q3 		$2.56B Buy
4,550,845
+724,562
+19% +$410M 1.38% 29
2025
Q2 		$2.01B Buy
3,826,283
+1,502,198
+65% +$838M 1.13% 35
2025
Q1 		$1.47B Buy
2,324,085
+2,769
+0.1% +$1.9M 0.84% 46
2024
Q4 		$1.65B Buy
2,321,316
+9,381
+0.4% +$7.87M 0.96% 41
2024
Q3 		$2.43B Sell
2,311,935
-3,751
-0.2% -$4.17M 1.37% 27
2024
Q2 		$2.43B Sell
2,315,686
-44,178
-2% -$42.8M 1.46% 24
2024
Q1 		$2.27B Sell
2,359,864
-7,816
-0.3% -$7.43M 1.32% 29
2023
Q4 		$2.08B Sell
2,367,680
-5,318
-0.2% -$4.38M 1.32% 28
2023
Q3 		$1.95B Sell
2,372,998
-21,357
-0.9% -$16.8M 1.32% 26
2023
Q2 		$1.72B Buy
2,394,355
+9,654
+0.4% +$7.44M 1.15% 28
2023
Q1 		$1.96B Buy
2,384,701
+161,642
+7% +$122M 1.34% 25
2022
Q4 		$1.6B Sell
2,223,059
-63,450
-3% -$46.8M 1.1% 33
2022
Q3 		$1.58B Buy
2,286,509
+21,175
+0.9% +$13.3M 1.19% 31
2022
Q2 		$1.34B Buy
2,265,334
+28,271
+1% +$18.4M 0.93% 44
2022
Q1 		$1.56B Buy
2,237,063
+1,957,941
+701% +$1.24B 0.95% 42
2021
Q4 		$176M Buy
+279,122
New +$172M 0.11% 85

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Dodge & Cox's REGN Position: Q2 2026 in Review

Dodge & Cox increased its Regeneron Pharmaceuticals (REGN) stake by 9.3% in Q2 2026, buying an estimated $281M and bringing the position to 4,871,137 shares worth $3.04B. The position accounts for 1.59% of the portfolio, ranked #18.

Dodge & Cox first reported a position in REGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $3.55B in Q4 2025. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Dodge & Cox held 4,871,137 shares of Regeneron Pharmaceuticals worth $3.04B as of Q2 2026.
  • Dodge & Cox bought 412,899 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $281M.
  • Regeneron Pharmaceuticals made up 1.59% of Dodge & Cox's portfolio in Q2 2026, its #18 holding.
  • Dodge & Cox first reported a position in Regeneron Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • Dodge & Cox's Regeneron Pharmaceuticals position peaked at $3.55B in Q4 2025.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Dodge & Cox's 13F filing for Q2 2026, filed 13 Aug 2026.